KENAN LUCAS - 26 Oct 2022 Form 4 Insider Report for STREAMLINE HEALTH SOLUTIONS INC. (STRM)

Role
Director
Signature
/s/ Kenan Lucas
Issuer symbol
STRM
Transactions as of
26 Oct 2022
Net transactions value
+$999,999
Form type
4
Filing time
28 Oct 2022, 14:26:04 UTC
Previous filing
09 Jun 2022
Next filing
10 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STRM Common Stock, $0.01 par value Purchase $999,999 +757,575 +19% $1.32 4,824,212 26 Oct 2022 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities were purchased from the Issuer in connection with a Registered Direct Offering (the "Offering") consummated on October 26, 2022. The foregoing description of the Offering does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on October 27, 2022, which is incorporated by reference.
F2 The securities are held in the account of Harbert Discovery Fund, LP (the "Fund") and may be deemed to be beneficially owned by Kenan Lucas, the managing director and portfolio manager of the general partner of the Fund.

Remarks:

The Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.